The role of intravenous iron in anemia management and transfusion avoidance. (ανοίγει νέο παράθυρο)

Auerbach M, Goodnough LT, Picard D, Maniatis A.

Πηγή‎: Transfusion 2008;48(5):988-1000.

Καταχώριση‎: PubMed 18346021

DOI‎: 10.1111/j.1537-2995.2007.01633.x

https://www.ncbi.nlm.nih.gov/pubmed/18346021 (ανοίγει νέο παράθυρο)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (ανοίγει νέο παράθυρο)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Πηγή‎: BJU Int 2011;108(10):1582-7.

Καταχώριση‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (ανοίγει νέο παράθυρο)

The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. (ανοίγει νέο παράθυρο)

Lepor H, Lipkin M, Slova D.

Πηγή‎: Urology 2010;75(6):1424-8.

Καταχώριση‎: PubMed 20513505

DOI‎: 10.1016/j.urology.2009.06.095

https://www.ncbi.nlm.nih.gov/pubmed/20513505 (ανοίγει νέο παράθυρο)

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. (ανοίγει νέο παράθυρο)

Nieder AM, Rosenblum N, Lepor H.

Πηγή‎: Urology 2001;57(4):737-41.

Καταχώριση‎: PubMed 11306393

https://www.ncbi.nlm.nih.gov/pubmed/11306393 (ανοίγει νέο παράθυρο)

Penny-wise and pound-foolish: the challenges of preoperative anaemia management. (ανοίγει νέο παράθυρο)

Rozental O, Cushing MM, Shander A, Isbister JP, Lasocki S, Meybohm P, Muñoz M, Spahn DR, Weiniger CF, Trentino KM, Girardi NI

Πηγή‎: Br J Anaesth 2023;131(2):214-21.

Καταχώριση‎: PubMed 37244835

DOI‎: 10.1016/j.bja.2023.04.038

https://pubmed.ncbi.nlm.nih.gov/37244835/ (ανοίγει νέο παράθυρο)